scholarly journals Biopince Full Core Biopsy Device for Percutaneous Lung Biopsy: A Retrospective Analysis of 184 Procedures Analyzing Complication Rates and Procedure Success

2021 ◽  
pp. 17-25
Author(s):  
Robert Bernstein ◽  
Ryan Garrow
Keyword(s):  
Core Biopsy ◽  
Lung Biopsy ◽  
Research Question ◽  
Outpatient Setting ◽  
High Rate ◽  
Complication Rates ◽  
Core Needle ◽  
Biopsy Device ◽  
Percutaneous Lung Biopsy ◽  
Full Core

Background: Unlike fine needle aspiration, core needle biopsies allow the collection of intact tissue for pathological and molecular evaluation. In outpatient clinical practice, full core needle lung biopsy may be underused because of concerns that it might be too dangerous. We describe our experience using a full core device for percutaneous lung biopsy in a large cohort of patients. Research Question: Is percutaneous full core needle lung biopsy effective and safe in the outpatient setting? Study Design and Methods: The analyzed population comprised patients with lung masses >1.1 cm who underwent percutaneous lung biopsy with a full core device. Analyzed data included core mass dimensions, distance from pleural edge to mass, lobe location, type, outcomes, and complications. Biopsy success was defined as adequate tissue acquisition for pathological evaluation that yielded a diagnosis. Biopsy procedures with incomplete data were excluded from this analysis. Results: We analyzed data from 184 lung biopsies performed on 182 patients (mean age, 70±11.7 years). Most biopsies were parenchymal (54.9%). The overall diagnostic success rate was 98.4%. No complications were reported for 77.2% of biopsies. Minor complications occurred during 39 biopsies (21.2%) and were primarily pneumothorax (16.8%). Major complications occurred during 4 biopsies (2.1%): 3 patients with pneumothorax required emergency department (ED) management and 1 patient went to the ED for severe pain. All complications resolved within 24 hours without hospitalization or transfusion. Crosstabulation analyses showed no significant differences between the lung lobe locations in terms of rates of disposition and complications, and between the lesion types in terms of rates of disposition and complications. Interpretation: Percutaneous lung biopsy performed using a full core biopsy device demonstrated a high rate of diagnostic success and a low risk of clinically significant procedural complications in an outpatient setting.

EliteCore Full Core Biopsy Device

2015 ◽  
Vol 45 (14) ◽  
pp. 109
Keyword(s):  
Core Biopsy ◽  
Biopsy Device ◽  
Full Core

Trustwide audit of percutaneous lung biopsy (PLB): delays and complication rates

Lung Cancer ◽  
2019 ◽  
Vol 127 ◽  
pp. S16
Author(s):  
E. Pegg ◽  
M. Maddock ◽  
P. Slaney ◽  
S. Elliott ◽  
P. Wilson
Keyword(s):  
Lung Biopsy ◽  
Complication Rates ◽  
Percutaneous Lung Biopsy

Fluoroscopy-guided percutaneous lung biopsy: a valuable alternative to computed tomography

2008 ◽  
Vol 49 (8) ◽  
pp. 876-882 ◽  
Author(s):  
L. A. Kurban ◽  
L. Gomersall ◽  
J. Weir ◽  
P. Wade
Keyword(s):  
Computed Tomography ◽  
Lung Biopsy ◽  
Computer Software ◽  
Complication Rates ◽  
Ct Guided ◽  
Alternative Modality ◽  
Chest X Ray ◽  
Percutaneous Lung Biopsy ◽  
The Mean ◽  
Lung Biopsies

Background: Computed tomography (CT) fluoroscopy nowadays is the most preferred method of guidance to perform percutaneous lung biopsy of pulmonary masses. Conventional fluoroscopy is an increasingly forgotten technique that still can be used to perform lung biopsies, with many advantages. Purpose: To compare the accuracy, safety, and effective dose (ED) of conventional fluoroscopy-guided needle lung biopsy (FNLB) with CT-guided needle lung biopsy procedures (CTNLB) reported in the literature. Material and Methods: 100 consecutive patients who underwent FNLB were reviewed retrospectively. Using the final histological diagnoses and the clinical and radiological course of the disease as references, the accuracy and sensitivity of FNLB were calculated. The complication rates of FNLB were assessed. Using computer software (XDOSE), the ED was calculated. The accuracy, complication rates, and the ED of FNLB were compared with CTNLB reported in the literature. Results: The overall accuracy rate and sensitivity of FNLB were both 87%, which are comparable to the range of accuracies reported in the literature for CTNLB (74–97%). The complication rates of FNLB were also comparable to the complication rates reported for CTNLB. The commonest complication was pneumothorax, at a rate of 25%. The ED of FNLB was small, significantly lower than reported in the literature for CT-guided procedures. The mean ED of FNLB was 0.029 mSv, which is approximately equivalent to one chest X-ray. Conclusion: Conventional fluoroscopy is an accurate, safe, and low-dose alternative modality to CT to obtain an image-guided histological diagnosis of pulmonary lesions.

scholarly journals CT guided lung biopsy: Diagnostic yield and complications, using 18G coaxial semi-automatic core needle

2019 ◽  
Vol 4 (1) ◽  
pp. 20-25
Author(s):  
Ajit Thapa ◽  
Kamal Subedi ◽  
Sundar Suwal ◽  
Dinesh Chataut
Keyword(s):  
Core Biopsy ◽  
Lung Biopsy ◽  
Diagnostic Yield ◽  
Lung Nodule ◽  
Histopathological Diagnosis ◽  
Safe Procedure ◽  
Ct Guided ◽  
Biopsy Needle ◽  
Core Needle ◽  
Clinically Significant

Introduction: CT guided biopsy is essential for histopathological diagnosis of suspicious lung nodule, which are not amenable for either bronchoscopic or sonography guided sampling. Methods: Twenty eight patients with suspicious lung nodules not amenable for bronchoscopic or sonography guided sampling who underwent CT guided lung biopsy with 18 G coaxial semiautomatic core biopsy needle in one year were retrospectively studied for diagnostic yield and complications. Results: Out of 28 patients, who underwent CT guided lung nodule biopsy, 18 were male and 10 were female. The age ranged from 22 to 80 years. Lesion size ranged from one cm to four cm and depth of lesion from pleura ranged from zero cm to five cm. Diagnostic yield of our core needle biopsy was 26(92.3%). Clinically significant complication was low. Massive pneumothorax which needed intercostal drainage was 7.14% (2 patients). Pulmonary hemorrhage manifesting as hemoptysis was seen in 14.3 %( 2 patients). No hemothorax or air embolism was noted in any of the patient. Conclusion: CT guided lung lesion biopsy with 18 G coaxial semi-automatic core biopsy needle is a safe procedure with good diagnostic yield and relatively low incidence of clinically significant complications.

Technique and diagnostic value of percutaneous lung biopsy in 66 horses with diffuse pulmonary diseases using an automated biopsy device

2007 ◽  
Vol 19 (3) ◽  
pp. 157-161 ◽  
Author(s):  
N. Pusterla ◽  
J. L. Watson ◽  
J. E. Madigan ◽  
W. D. Wilson
Keyword(s):  
Lung Biopsy ◽  
Diagnostic Value ◽  
Pulmonary Diseases ◽  
Biopsy Device ◽  
Percutaneous Lung Biopsy

Diagnosis of Diffuse Lung Disease by Cutting Needle Biopsy

1994 ◽  
Vol 35 (3) ◽  
pp. 251-254 ◽  
Author(s):  
P. Lohela ◽  
T. Tikkakoski ◽  
K. Ämmälä ◽  
L. Strengell ◽  
I. Suramo ◽  
...  
Keyword(s):  
Lung Disease ◽  
Needle Biopsy ◽  
Lung Biopsy ◽  
Open Lung Biopsy ◽  
Histologic Diagnosis ◽  
Diffuse Lung Disease ◽  
Biopsy Device ◽  
Percutaneous Lung Biopsy ◽  
Diffuse Lung ◽  
Cutting Needle

The results of 15 consecutive automated cutting needle (1.2 mm, n = 14; 2.0 mm, n = 1) biopsies of diffuse lung manifestations are presented. Sufficient material for histologic analysis was obtained in 13 of 15 specimens (87%) and a specific diagnosis was obtained in 11 of 14 patients (79%). The tissue specimen confirmed the clinically probable lung disease in 6 patients, gave a new, unsuspected, diagnosis in 2, and resolved a differential diagnostic problem in 3 patients. One pneumothorax after a 2.0-mm needle biopsy necessitated catheter drainage. We conclude that percutaneous lung biopsy with the automated biopsy device mounted with a 1.2-mm needle yields a histologic diagnosis with high accuracy in interstitial and alveolar lung changes, reducing the need for more invasive methods such as open lung biopsy.

Neurofeedback for Opioid Dependent Patients in an Outpatient Setting: A Pilot Feasibility Study

2021 ◽  
Author(s):  
Helena A. Rempala ◽  
Justin A. Barterian
Keyword(s):  
Large Scale ◽  
The United States ◽  
Outpatient Setting ◽  
Opioid Use Disorder ◽  
High Rate ◽  
Treatment Center ◽  
Opioid Use ◽  
Treatment As Usual ◽  
Factors Affecting ◽  
Study Approach

Abstract Background: Neurofeedback (NF) has been described as “probably efficacious” when used in conjunction with other interventions for substance use disorders, including the most recent studies in population of individuals with opioid use disorder. Despite these promising outcomes, the seriousness of the opioid epidemic, and the high rate of relapse even with the most effective medication-assisted maintenance treatments NF continues to be an under-researched treatment modality. This article explores factors that affected the feasibility of adding Alpha/Theta Neurofeedback to treatment as usual for opioid dependence in an outpatient urban treatment center. The study strived to replicate previous research completed in Iran that found benefits of NF for opioid dependence.Methods: Out of approximately two dozen patients eligible for Alpha/Theta NF, about 60% (n=15) agreed to participate; however, only 2 participants completed treatment. The rates of enrollment in response to active treatment were monitored. Results: The 4 factors affecting feasibility were: 1) the time commitment required of participants, 2) ineffectiveness of standard incentives to promote participation, 3) delayed effects of training, and 4) the length and number of treatments required.Conclusion: The findings indicate a large scale study examining the use of NF for the treatment of opioid use disorder in the United States will likely be difficult to accomplish without modification to the traditional randomized control study approach and suggests challenges to the implementation of this treatment in an outpatient setting.

Systemic arterial air embolism after percutaneous lung biopsy

2011 ◽  
Vol 66 (7) ◽  
pp. 589-596 ◽  
Author(s):  
S.S. Hare ◽  
A. Gupta ◽  
A.T.C. Goncalves ◽  
C.A. Souza ◽  
F. Matzinger ◽  
...  
Keyword(s):  
Lung Biopsy ◽  
Air Embolism ◽  
Percutaneous Lung Biopsy

scholarly journals A Comparison Between Core Biopsy and Imaging Techniques (Ultrasound and Mammography) In diagnosis of Breast Cancer in Slemani Breast Center

2018 ◽  
Vol 3 (1) ◽  
pp. 34-39
Author(s):  
Taher Abdullah Hawramy ◽  
Dara Ahmed Mohammed ◽  
Hasan Abdullah Ahmed
Keyword(s):  
Breast Cancer ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Core Biopsy ◽  
Imaging Techniques ◽  
Breast Cancers ◽  
Radiological Investigation ◽  
Core Needle ◽  
Breast Center ◽  
Study Results

Breast cancer is the global health problem. It is the highest prevalent site-specific cancer in women throughout the world and the most common reason of death in middle age women,  following lung cancer. Up to 5% of breast cancers are caused by inheritance. Male breast cancer accounts for less than 1%. Mammography is the first imaging study to evaluate breast abnormalities, Ultrasound is particularly useful in young women with dense breasts. Core needle biopsy permits the analysis of breast tissue architecture and whether invasive cancer is present. To compare core needle biopsy and imaging, the accuracy of each modality for purpose of the diagnosis and their impact on preoperative planning before surgical treatment. A retrospective cohort study was performed in 70 cases of breast cancer during 2015-2017 at Slemani Breast Center/ Kurdistan region. Inclusion criteria any patient with diagnosed with breast cancer for whom core biopsy and imaging techniques (ultrasound and mammography) were done, Age 25 years and above. Exclusion criteria, a patient with breast mass who did not underwent: one of the two modalities, Age below 25 years, pregnant women. In the current study: mean age/year for the  participants were Mean age = 51.34 year ± 12.85 SD), Sixty-nine cases were female and one male. By core biopsy (97.1%) is positive for malignancy. In this study: results about 34.28% of BIRADS V (ultrasound)lesions proved to be positive for malignancy by core biopsy, 1.43% of BIRADS V were negative for malignancy and the association was statistically highly significant, for BIRADS III lesions 17.14% were proved as positive for malignancy by core biopsy. About 45.7% of BIRADS V (mammography were positive for malignancy by core biopsy and the associations were found to be statistically highly significant and for BIRADS III 12.85% of lesions were positive for malignancy by core biopsy. There was a statistically significant association between radiological investigation(ultrasound, mammography) and histopathological finding (core biopsy).  

Sign in / Sign up

Export Citation Format

Share Document